CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioelectronics Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioelectronics Corp
4539 Metropolitan Ct
Phone: (301) 874-4890p:301 874-4890 FREDERICK, MD  21704-9452  United States Ticker: BIELBIEL

This company ceased filing statements with the SEC on 4/18/2011.

Business Summary
BioElectronics Corporation is an electroceutical company. The Company develops wearables, neuromodulation devices to mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. Its flagship product, the ActiPatch Musculoskeletal Pain Therapy, is developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours of on/off therapy. The Company is also focused on international customers to expand its distributions and sales. The neuromodulation basis of PSWT presents significant opportunities for it to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202112/31/2021YesYes-YesYes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board RichardStaelin 74 6/15/2020 4/1/2005
President, Chief Executive Officer, Treasurer, Director Kelly A.Whelan 11/14/2019 11/14/2019
Vice President - Sales, Director Keith E.Nalepka 11/14/2019 11/14/2019
5 additional Officers and Directors records available in full report.

Business Names
Business Name
BIEL
BioElectronics Corp
Bioelectronics Corp.

General Information
Number of Employees: 9 (As of 12/31/2009)
Outstanding Shares: 24,705,066,971 (As of 3/31/2022)
Shareholders: 183
Stock Exchange: OTC
Federal Tax Id: 522278149
Fax Number: (301) 874-6935


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, February 23, 2024